(Q35545999)

8 August 2017

1 reference

title

Contemporary management of rhinosinusitis and cystic fibrosis (English)

1 reference

8 August 2017

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

15 March 2024

author name string

Raj Tandon

1

1 reference

8 August 2017

Craig Derkay

2

1 reference

8 August 2017

language of work or name

1 reference

1 February 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00020840-200302000-00009

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Current Opinion in Otolaryngology & Head and Neck Surgery

15 March 2024

published in

1 reference

8 August 2017

11

1 reference

8 August 2017

1

1 reference

8 August 2017

41-44

1 reference

Management and care of the newly diagnosed patient with cystic fibrosis.

8 August 2017

1

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Head and neck manifestations of cystic fibrosis and ciliary dyskinesia

15 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Recent advances in cystic fibrosis

15 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

The molecular biology of nasal polyposis

15 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management

15 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis.

15 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Long-term azithromycin may improve lung function in children with cystic fibrosis

15 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage

15 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

New antimicrobials in the management of cystic fibrosis

15 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial

15 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis

15 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Functional endoscopic sinus surgery in the paediatric population: outcome of a conservative approach to postoperative care.

15 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis.

15 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Image-guided functional endoscopic sinus surgery

15 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

Rhinosinusitis in transplant patients

15 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00020840-200302000-00009

15 March 2024

Identifiers

1 reference

8 August 2017

1 reference